spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

6th Annual Cancer Vaccines Conference

SMI - 6th annual Cancer Vaccines Conference

27-28 September 2017
Copthorne Tara Hotel, London UK

Cancer Vaccines 2017: Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies.

SMi Group is thrilled to present the 6th annual Cancer Vaccines conference, taking place on 27th & 28th September 2017 in Central London, UK. Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies.

Aimed at an audience of senior scientists and oncology specialists involved in targeted vaccines and drug research, Cancer Vaccines 2017 will provide a perfect platform to discuss pioneering clinical developments and the next generation of cancer immunotherapy. The 6th annual show will capture expert insight by honing in on new pathways with novel vaccines and immunotherapies, drug formulations, personalised treatment, immune check-point inhibitors, plus more.

Join us this September for strategic direction on vaccine commercialisation and arm yourself with the key requirements and tools for successful vaccine development through informed guidance delivered by a top panel of speakers.

Featured Speakers:

Steve Doberstein, Senior Vice President and Chief Scientific Officer, Nektar
Kandeepan Ganeshalingam, Executive Director, Therapeutic Area Head Oncology, MSD
Fatema Legrand, Senior Clinical Scientist, Genentech
David Giljohann, CEO, Exicure
Steve Doberstein, Senior Vice President and Chief Scientific Officer, Nektar
Agnete Fredriksen, Chief Scientific Officer, Vaccibody
Mads Hald Andersen, Professor and Vice-Director, Centre for Cancer Immune Therapy, Copenhagen University Hospital; Founder, IO Biotech
Rose-Ann Padua, Research Director, INSERM
Zahra Jawad, Group Leader in Discovery Technology, Agenus

Exclusive highlights in 2017:

Exploring personalising cancer vaccines, characterising and applying the outside in approach in cancer vaccine development
Maximising the therapeutic potential of cancer vaccines in combination with immune checkpoint inhibitors
In depth case study examples of peptide, DNA, neoantigen and MHC based vaccine development
Assessing the use of preclinical data for cancer vaccines

Cancer Vaccines 2017 is sponsored by Northwest Biotherapeutics
phone +44 (0) 207 827 6012
email kwilliams@smi-online.co.uk
web bit.ly/2rAmHA3
email Copthorne Tara Hotel, London
 
Print this page
Send to a friend
   
spacer
Industry Events

6th Annual Single Cell Analysis Congress

8-9 November 2018, London, UK

Oxford Global is proud to present its 6th Annual Single Cell Analysis Congress taking place on 8-9 November 2018 in London.  Part of the Genomics & Synthetic Biology Series UK, the congress will bring together over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.
More info >>

White Papers

Crossing the Blood Brain Barrier (BBB): Which Route to Take?

Aptar Pharma

Aptar Pharma recently hosted an expert panel/roundtable on the various approaches to treating central nervous system (CNS) diseases. This international scientific forum was held in Paris, France on December 5th, 2014. The roundtable was organized to explore and exchange views on the challenges, approaches and opportunities that exist with regard to effectively crossing the blood brain barrier (BBB) and successfully treating a host of CNS diseases.
More info >>


News and Press Releases

Biologics Day

On 20. July 2018, Phenomenex and SCIEX will co-host a full day of seminars, providing solutions for Biologics. The series of mini-seminars presented by technical experts from both companies, will cover methods for characterisation and QC testing, troubleshooting and new trends in analysis for this industry.  
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement